Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-06-28 07:30 |
Valneva Shareholders Approve all Resolutions Recommended by the Management Boar…
|
English | 407.7 KB | ||
| 2019-06-28 07:30 |
Les actionnaires de Valneva approuvent toutes les résolutions recommandées par …
|
French | 407.8 KB | ||
| 2019-06-26 20:59 |
Voltalia SA : SNCF Energie et Voltalia signent le premier contrat d'achat direc…
|
English | 49.7 KB | ||
| 2019-06-26 20:59 |
Voltalia SA: SNCF Energie and Voltalia sign a very long-term direct power purch…
|
English | 53.1 KB | ||
| 2019-06-13 08:30 |
Voltalia franchit le cap du gigawatt installé ou en construction
|
English | 83.2 KB | ||
| 2019-06-13 08:30 |
Voltalia crosses the 1 GW in operation or construction milestone
|
English | 89.0 KB | ||
| 2019-06-12 17:50 |
Valneva Reports Successful Outcome of Phase 2 Run-In for its Lyme Disease Vacci…
|
English | 492.6 KB | ||
| 2019-06-12 17:50 |
Valneva annonce le succès de la première étape de Phase 2 pour son vaccin contr…
|
French | 629.4 KB | ||
| 2019-06-11 17:50 |
VALNEVA fera un point sur l’avancée de ses programmes de vaccins Lyme et chikun…
|
French | 629.4 KB | ||
| 2019-06-11 17:50 |
Valneva to Present Lyme Disease and Chikungunya Vaccine Updates at R&D Investor…
|
English | 492.6 KB | ||
| 2019-06-06 07:00 |
2019_06_06_VLA_Availability_of_AGM_documents_PR_FR
|
French | 357.1 KB | ||
| 2019-05-22 07:00 |
2019_05_22_VLA_Chik_Results_PR_FR
|
French | 800.7 KB | ||
| 2019-05-22 07:00 |
2019_05_22_VLA_Chik_Results_PR_EN
|
English | 517.2 KB | ||
| 2019-05-06 18:00 |
Déclaration d'actions et de droits de vote Avril 2019 - Valneva
|
French | 9.4 KB | ||
| 2019-05-02 07:00 |
2019_05_02_VLA_Q1_Results_PR_FR
|
French | 787.9 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
